glp 1 and gip agonist The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GIP Receptor Agonism Attenuates GLP-1
Description
Medullary thyroid cancer: Rare thyroid cancer linked to GLP-1 use in animal studies
Increased FFA in the liver results in insulin resistance, hepatic glucose production, and pancreatic beta cell dysfunction [7]
Along with truncating the C-terminal, this exposes exenatide to NEP 24.11 degradation
doi: 10.1097/FJC.0b013e3182949673
